Growth Metrics

LifeMD (LFMD) Payables (2016 - 2025)

LifeMD filings provide 14 years of Payables readings, the most recent being $14.9 million for Q4 2025.

  • On a quarterly basis, Payables rose 27.78% to $14.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $14.9 million, a 27.78% increase, with the full-year FY2025 number at $14.9 million, up 27.78% from a year prior.
  • Payables hit $14.9 million in Q4 2025 for LifeMD, down from $20.3 million in the prior quarter.
  • In the past five years, Payables ranged from a high of $129.2 million in Q1 2024 to a low of $9.5 million in Q1 2023.
  • Median Payables over the past 5 years was $13.9 million (2021), compared with a mean of $20.2 million.
  • Biggest five-year swings in Payables: skyrocketed 2249.07% in 2021 and later plummeted 87.26% in 2025.
  • LifeMD's Payables stood at $10.0 million in 2021, then skyrocketed by 36.89% to $13.7 million in 2022, then decreased by 11.71% to $12.1 million in 2023, then dropped by 3.29% to $11.7 million in 2024, then grew by 27.78% to $14.9 million in 2025.
  • The last three reported values for Payables were $14.9 million (Q4 2025), $20.3 million (Q3 2025), and $25.1 million (Q2 2025) per Business Quant data.